Four-time Grand Slam winner Naomi Osaka has started sports agency Evolve with her agent Stuart Duguid after the Endeavor-owned IMG refused to accommodate her requests for more flexibility in their contract negotiations.
Osaka's contract with IMG expired at the end of 2021.
Both the 24-year-old Osaka and Stuart Duguid, who has also left IMG, will hold equity stakes in the new company and there are no external investors at this stage.
Osaka, the highest-paid female athlete in the world, has a commercial portfolio that includes deals with Panasonic, Workday, Tag Heuer, Louis Vuitton, Nike, Beats by Dre, and Mastercard. She also has equity in multiple companies, including Hyperice, Sweetgreen, Modern Health, FTX, Autograph and StatusPro.
Osaka said she wants Evolve to be at the forefront of breaking down the barriers that still remain in sports and culture.
Evolve's goal, according to Duguid, is not to grow into a large agency, and it would likely just take on another client or two. Osaka will be the main emphasis.
Evolve's main goal is to grow Naomi's business from $50 million to $150 million each year.


Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
How did sport become so popular? The ancient history of a modern obsession
Trump Plans UFC Event at White House for America’s 250th Anniversary
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
U.S. Stock Futures Slip as Year-End Trading Turns Cautious
Trump Set to Announce Washington D.C. as Host of 2027 NFL Draft
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
South Korea Inflation Rises to 2.3% in December, Matching Market Expectations
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Wall Street Ends Mixed as Tech and Financial Stocks Weigh on Markets Amid Thin Holiday Trading
Asian Stock Markets Trade Narrowly as Year-End Volumes Thin, KOSPI Outperforms on Tech Rally
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 



